Gyroscope secures $148M to develop treatment for rare eye diseases
Longevity Technology - 29-Mar-2021Funds to advance gene therapy for age-related macular degeneration & innovative delivery system
Join the club for FREE to access the whole archive and other member benefits.
General partner at Forbion and Board member at Gyroscope Therapeutics
Visit website: https://forbion.com/en/team/wouter_joustra
See also: Gyroscope Therapeutics - London-based company developing gene therapies and delivery technologies for eye diseases
Details last updated 31-Mar-2021
Funds to advance gene therapy for age-related macular degeneration & innovative delivery system